Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 USD | -2.38% | -4.09% | -44.03% |
Apr. 11 | BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target | MT |
Apr. 02 | HC Wainwright Adjusts Price Target on Carisma Therapeutics to $9 From $11, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.03% | 69.79M | |
-2.62% | 104B | |
+1.16% | 97.42B | |
+0.90% | 22.2B | |
-18.04% | 21.23B | |
-10.65% | 18.33B | |
-42.33% | 16.35B | |
-17.78% | 15.06B | |
+5.40% | 13.98B | |
+27.72% | 11.66B |
- Stock Market
- Equities
- CARM Stock
- News Carisma Therapeutics, Inc.
- Sesen Bio : Jefferies & Co Downgrades Sesen Bio to Hold From Buy, Adjusts PT to $1.50 From $6